Health
Top in hem/onc: Checkpoint inhibitor indications, loneliness of childhood cancer survivors – Healio
Last week, an FDA panel voted against maintaining a gastric cancer indication for pembrolizumab and a hepatocellular carcinoma indication for nivolumab. It was…
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected] to Healio
Last week, an FDA panel voted against maintaining a gastric cancer indication for pembrolizumab and a hepatocellular carcinoma indication for nivolumab. It was the top story in hematology/oncology.
Another top story revealed childhood cancer survivors have an elevated risk for feelings of loneliness due to isolation during their cancer experience….
-
Business14 hours agoWhy did this ASX 200 healthcare stock crash 14% yesterday?
-
General22 hours agoRussia launches hundreds of drones and missiles against Ukraine in fresh attack
-
Business16 hours agoOwn Xero shares? Here are 3 key takeaways from its AGM
-
General14 hours agoPatients speak out after Brisbane doctor accused of ‘excessive’ pap smears, kissing woman on lips